Antibodies

10 Aug 2018 Celltrion Begins Global Phase 3 Clinical Trial for Its Bevacizumab Biosimilar 'CT-P16'
10 Aug 2018 JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer
09 Aug 2018 BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China
09 Aug 2018 Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome
08 Aug 2018 Genmab Announces Submission of U.S. & EU Regulatory Applications Seeking Approval of DARZALEX® (Daratumumab) Split Dosing Regimen
08 Aug 2018 ADC Therapeutics Doses First Patient in Pivotal Clinical Trial of ADCT-402 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
08 Aug 2018 MorphoSys and I-Mab Biopharma Announce China IND Submission of TJ202/MOR202
07 Aug 2018 Celltrion Enters into Phases 1 and 3 Clinical Trials for the Adalimumab Biosimilar 'CT-P17'
07 Aug 2018 TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis
07 Aug 2018 TACTI-mel Patient Recruitment Complete and Operational Update
06 Aug 2018 Harpoon Therapeutics Treats First Patient with HPN424 in Phase 1 Clinical Trial of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
06 Aug 2018 Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers
02 Aug 2018 Bayer receives approval of new treatment regimen for Eylea® in the EU
02 Aug 2018 Clover Biopharmaceuticals Initiates Phase I Study of Etanercept Biosimilar Candidate SCB-808 in China
02 Aug 2018 Emergent BioSolutions Initiates Phase 1 Clinical Study of Zika Virus Immune Globulin Therapeutic
31 Jul 2018 European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lymph Nodes or Metastatic Disease Who Have Undergone Complete Resection
31 Jul 2018 Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)
31 Jul 2018 Immutep’s LAG-3 Immunostimulant Product Candidate, Efti, Receives IND Approval From U.S. FDA
31 Jul 2018 Novartis marks a new era for migraine patients with the EU approval of Aimovig®, a first-of-its-kind treatment specifically designed for migraine prevention
30 Jul 2018 Arcus Biosciences Announces Initiation of Phase 1 Trial for AB154, its Anti-TIGIT Antibody
30 Jul 2018 Opthea Doses First Patient in Phase 2a Trial for OPT-302 in Diabetic Macular Edema
30 Jul 2018 European Medicines Agency Adopts Positive Opinion for KEYTRUDA® (pembrolizumab) Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer
30 Jul 2018 Kymab Announces Promising Results from Initial Clinical Study of New Antibody KY1005 for Treatment of Autoimmune Diseases
27 Jul 2018 Imfinzi receives positive EU CHMP opinion for locally-advanced, unresectable non-small cell lung cancer
27 Jul 2018 Sandoz receives European Commission approval for biosimilar Hyrimoz® (adalimumab)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top